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Background: Traditional cohort studies are important contributors to our understanding of inflammatory bowel diseases, but
they are labor intensive and often do not focus on patient-reported outcomes. Internet-based studies provide new opportunities
to study patient-reported outcomes and can be efficiently implemented and scaled. If a traditional cohort study was linked to an
Internet-based study, both studies could benefit from added synergy. Existing cohort studies provide an opportunity to develop
and test processes for cohort linkage. The Crohn’s and Colitis Foundation of America’s (CCFA) Partners study is an Internet-based
cohort of more than 14,000 participants. The Ocean State Crohn’s and Colitis Area Registry (OSCCAR) is an inception cohort.
The Sinai-Helmsley Alliance for Research Excellence (SHARE) is a multicentered cohort of inflammatory bowel disease patients.
Both the later cohorts include medical record abstraction, patient surveys, and biospecimen collection.
Objective: Given the complementary nature of these existing cohorts, we sought to corecruit and link data.
Methods: Eligible OSCCAR and SHARE participants were invited to join the CCFA Partners study and provide consent for
data sharing between the 2 cohorts. After informed consent, participants were directed to the CCFA Partners website to complete
enrollment and a baseline Web-based survey. Participants were linked across the 2 cohorts by the matching of an email address.
We compared demographic and clinical characteristics between OSCCAR and SHARE participants who did and did not enroll
in CCFA Partners and the data linkage.
Results: Of 408 participants in the OSCCAR cohort, 320 were eligible for participation in the CCFA Partners cohort. Of these
participants, 243 consented to participation; however, only 44 enrolled in CCFA Partners and completed the linkage. OSCCAR
participants who enrolled in CCFA Partners were better educated (17% with doctoral degrees) than those who did not (3% with
doctoral degrees, P=.01). In the SHARE cohort, 436 participants enrolled and linked to the Partners cohort. More women (60%
vs 50%) linked and those who linked were predominantly white (96%; P<.01). Crohn’s disease patients who linked had lower
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mean scores on the Harvey-Bradshaw Index (3.6 vs 4.4, P<.01). Ulcerative colitis patients who linked had less extensive disease
than those who did not link (45% vs 60%, P<.01).
Conclusions: Linkage of CCFA Partners with cohorts such as OSCCAR and SHARE may be a cost-effective way to expand
the infrastructure for clinical outcomes and translational research. Although linkage is feasible from a technical, legal, and
regulatory perspective, participant willingness appears to be a limiting factor. Overcoming this barrier will be needed to generate
meaningful sample sizes to conduct studies of biomarkers, natural history, and clinical effectiveness using linked data.
(J Med Internet Res 2016;18(6):e124)  doi: 10.2196/jmir.5655
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Introduction
Cohort studies are designed to evaluate risk factors for
developing a health condition and/or factors which affect the
natural history of disease [1]. In traditional cohort studies,
subjects are extensively characterized at baseline (eg health
history, environmental exposures), often with the collection of
biosamples and observed over time for the development of
outcomes of interest. These outcomes usually include important
medical events such as surgery, cancer, or death. In recent years,
there has been growing interest in the use of the Internet and
social media to develop electronic cohorts, which focus on
patient-reported exposures and health behaviors and
patient-reported outcomes (PROs) such as fatigue, well-being,
and illness experience [2-5]. Electronic cohorts have the
advantage of efficient recruitment and data collection and may
be less costly to maintain over time. Linking a traditional cohort
with an electronic cohort offers an opportunity to derive the
benefits of both cohort designs. This hybrid cohort would have
the benefit of well-characterized, validated cases and biological
specimens. The speed and low cost of the electronic component
would provide a cost-effective approach to evaluate an extended
array of PROs. Translational studies could exploit the biological
samples in the hybrid cohort.
Two novel and complementary cohort studies initiated by the
Crohn’s and Colitis Foundation of America (CCFA) provide
an opportunity to develop and test the process of cohort linkage.
The Ocean State Crohn’s and Colitis Area Registry (OSCCAR),
a traditional cohort study, is an inception cohort that includes
medical record abstraction, patient surveys, and biospecimen
collection. CCFA Partners is an electronic cohort of more than
14,000 participants with inflammatory bowel diseases (IBDs)
that focuses on patient-reported exposures and outcomes. In
addition, IBD patients enrolled in the Sinai-Helmsley Alliance
for Research Excellence (SHARE), a 7-center prospective
observation cohort, were also evaluated to test the linkage of a
traditional cohort to an electronic cohort. As these cohorts have
different areas of focus, they are complementary to one another.
If successful, linkage would provide a cost-effective strategy
to expand the data assets of both cohorts, enabling studies not
possible in either cohort alone. Record linkages of this kind
have the potential to create information-rich environments [6]
allowing for a more patient-centered and holistic approach to
observational research, patient care, and improved patient
outcomes.
Other record linkage initiatives have been established around
the world for a variety of research purposes. For example,
Australia’s Population Health Research Network is expected
to be the world’s “largest population database supporting health
research, policy, and planning” and links together a number of
health administrative databases [7]. Researchers in Canada are
working to link health administration data with data from the
Canadian Longitudinal Study on Aging cohort and the Canadian
Partnership for Tomorrow Project cohort [8]. An initiative in
the United Kingdom aimed to link PRO measures reported
through an Web-based data collection system to clinical data
in a cancer registry [9]. To our knowledge, our study represents
the first published attempt to link data from a traditional,
inception cohort to a large electronic cohort.
The objectives of this project were (1) to develop the technical,
regulatory, and legal infrastructure to corecruit OSCCAR and
SHARE participants and into CCFA Partners and link the data
assets of these 2 cohorts and (2) to evaluate the feasibility of
this corecruitment and linkage process. If successful, linkage
of these cohorts would produce a “virtual database” of expanded




OSCCAR is a novel, community-based inception cohort of 408
Crohn’s disease (CD) and ulcerative colitis (UC; IBD subtypes)
patients launched in Rhode Island in 2008 and closed to
enrollment in 2013. Funded by the Centers for Disease Control
and Prevention, investigators at Mount Sinai Hospital, Harvard
Medical School, and the Warren Alpert Medical School of
Brown University jointly manage the OSCCAR cohort. The
cohort is designed to collect data on incidence rates of CD and
UC, disease outcomes, and factors predictive of disease onset
and outcomes. In addition to the prospective and longitudinal
collection of clinical data by physician report and chart
abstraction, OSCCAR participants complete regular surveys
and contribute to a biobank of blood, urine, and stool specimens
[10].
Newly diagnosed pediatric and adult patients with IBD who
were residents of Rhode Island were referred by their diagnosing
gastroenterologist or surgeon for enrollment in OSCCAR from
January 2008 to January 2013. After informed consent, diagnosis
of IBD was confirmed by chart review by medically trained
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study personnel according to standard criteria of the National
Institutes of Diabetes and Digestive and Kidney Diseases IBD
Genetic Consortium. Participants were visited at study
enrollment and requested to provide blood, urine, and stool
samples. All subjects were also asked to complete the
Inflammatory Bowel Disease Questionnaire, IMPACT
Questionnaire, Short Form Health Survey (SF)-36, EuroQoL
5, Work Productivity and Activity Impairment Questionnaire,
Functional Assessment of Chronic Illness Therapy, Short
Inflammatory Bowel Disease Questionnaire, An Assessment
of Environmental Risks for Ulcerative Colitis and Crohn’s
Disease in the United States, and PHQ-8 Depression Diagnostic
and Severity Measure [11-17]. Subjects with CD were asked to
complete the Harvey-Bradshaw Index (HBI). Subjects with UC
were asked to complete the Simple Clinical Colitis Activity
Index (SCCAI). The participants are contacted every 6 months
through the study period to update their profiles and collect
specimens [10, 18].
Share
The SHARE is a prospective observational cohort of patients
with IBDs. The cohort was established with the goal of creating
a database of clinical information and a repository of biological
specimens for genetic, molecular, and microbiological research
to better understand IBD and to help develop new therapies.
Starting in July 2012, patients were recruited from 7 academic
centers around the United States: Mount Sinai Hospital,
University of Chicago Medical Center, Massachusetts General
Hospital, Cedars-Sinai Medical Center, Mayo Clinic, Rochester,
University of North Carolina at Chapel Hill Hospital, and
Washington University, Saint Louis, Medical Center. Enrollment
is currently ongoing.
Patients who are aged younger than 18 years, unable to
understand or provide informed consent, and do not have a
confirmed diagnosis of IBD in their medical records were
excluded. Recruited patients provided demographic information,
medical history, surgical history, family history, medication
use, extraintestinal manifestations, and blood samples via an
interview with a study coordinator. Disease characteristics,
medication use, extraintestinal manifestations, and laboratory
results are obtained from the medical record by the study
coordinator. The HBI, SCCAI, and Modified Pouchitis Disease
Activity Index are completed during the study visit by the
investigator or a study coordinator [19-21]. The Depression
Activity and Severity Index (PHQ-8) and Manitoba Index are
completed by the patient during the study visit [17, 22].
CCFA Partners
CCFA Partners is a validated, Internet-based, long-term cohort
study of adult subjects with IBD initiated in July 2011 and
administered by the University of North Carolina, Chapel Hill.
The development of CCFA Partners has been described in detail
previously [23]. In brief, participants with a self-reported
diagnosis of UC, CD, or indeterminate colitis were recruited
through CCFA email rosters, the CCFA website, social media
outlets, and at educational and fundraising events. The baseline
and subsequent surveys administered every 6 months include
questions regarding demographics, disease type, disease course
and activity, IBD-related treatments, and concurrent medication
use including alternative medicines, family history of disease,
diet, exercise, and PROs including quality of life and medication
adherence [23]. To date, over 14,000 people with IBD have
been enrolled. Published and planned studies using data
generated from the CCFA Partners e-cohort include the
evaluation of (1) the impact of IBD on important,
patient-centered outcomes, (2) the role of environmental
influences (eg, sleep, depression, diet, exercise) on disease
activity, (3) patient perceptions on selected topics such as quality
of care, biobanking, and so forth, and (4) clinical effectiveness
and drug safety research [24-29]. Further details on the




To enable record linkage, we identified members of OSCCAR
and SHARE who met the criteria for membership in CCFA
Partners, including having a diagnosis of IBD and access to the
Internet.
Education and Recruitment
OSCCAR participants are seen in person at years 1 and 5 after
enrollment and are contacted by phone every 6 months. During
these points of contact, OSCCAR staff provided participants
with recruitment materials about the CCFA Partners cohort and
the OSCCAR-CCFA Partners linkage study. Participants were
also provided with the CCFA Partners Web address for
additional information. All OSCCAR participants were
contacted on at least three occasions.
SHARE participants were asked if they were interested in
participating in CCFA Partners at the time of their enrollment
in SHARE between July 2012 and December 2014. Cedars-Sinai
Medical Center did not participate in this linkage study.
Linkage
Participants were linked across the 2 cohorts by the matching
of their email addresses. After informed consent for the data
linkage, participants were sent an automated email with
instructions on how to access the CCFA Partners website to
complete CCFA Partners enrollment/consent and to fill out the
baseline survey. Each participant was sent up to three email
reminders. In addition, in the OSCCAR cohort, the study
coordinator and research assistants sent personalized letters and
made phone calls to each individual to encourage completion
of the linkage process.
Ethics
The study protocol was approved by the Institutional Review
Boards at Rhode Island Hospital, the University of North
Carolina at Chapel Hill, and the Institutional Review Boards of
the SHARE sites that participated. Personal health information
was protected across linkages by using deidentified study
identification numbers. Where necessary, personal identifiers
for consented participants were made available to trained
research staff identifiers through a password-protected Web
portal.
J Med Internet Res 2016 | vol. 18 | iss. 6 | e124 | p. 3http://www.jmir.org/2016/6/e124/
(page number not for citation purposes)




The enrolled subjects were compared to the unenrolled subjects.
Categorical variables were compared using Fisher’s exact tests
or chi-square tests as appropriate and continuous variables were
compared using t tests. All P values less than .05 were
considered statistically significant. Analyses were performed
using SAS 9.4 (SAS Institute, Cary, NC) and Stata 14.0
(StataCorp, College Station, TX).
Results
OSCCAR
Figure 1 illustrates the recruitment process for the CCFA
Partners/OSCCAR linkage. A total of 408 participants have
been enrolled in OSCCAR. Seventy-six of these subjects are
no longer being followed because of voluntary withdrawal, loss
to follow-up, criteria insufficient for a diagnosis of IBD, or
death. An additional 12 subjects report not having access to the
Internet. Of the remaining 320 participants who were eligible
for linkage, all were approached for participation. Two hundred
forty-three subjects consented to linkage with the Partners
cohort, 25 declined participation, and the remaining 52 did not
respond to recruitment efforts. Of those who consented to
participation, 44 (14% of those eligible) completed the linkage.
Table 1 shows characteristics of OSCCAR cohort members
who were successfully enrolled in and completed linkage with
CCFA Partners compared with members who did not. The
OSCCAR cohort is predominantly white (97%) and race did
not appear to influence CCFA Partners enrollment and linkage.
The mean age at diagnosis was 34 years in the linked group and
33 years in the unlinked groups. Similarly, disease type did not
affect enrollment. Of those who completed linkage, 28 (63%)
had CD and of those who did not 192 (60%) had CD. Fourteen
(32%) and 122 (38%) of linked and unlinked subjects were
diagnosed with UC, respectively.
OSCCAR participants who were successfully recruited into
CCFA Partners were more educated (8 participants [17%] with
a doctoral degree) than those who were not (7 participants [3%]
with a doctoral degree, P=.01). Similarly, those who did not
enroll in CCFA Partners were numerically more likely to have
not attained a bachelor’s degree than those who did enroll;
however, this was not statistically significant. There were no
other significant demographic or clinical differences (eg, disease
activity, disease behavior, disease location, medication use).
Figure 1. Recruitment efforts for the CCFA Partners/OSCCAR record linkage.
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Share
Of the SHARE participants from July 2012 to December 2014
who were approached to enroll in the CCFA Partners cohort,
1671 (75%) consented to linkage. However, only 24% (n=436)
completed the linkage by enrolling in the Partners cohort (see
Figure 2). Enrollment varied by study center. Table 2 shows
characteristics of SHARE cohort members who were
successfully enrolled in and completed linkage with CCFA
Partners compared with members who did not. Gender was a
notable difference: of those who linked, 263 (60%) were women,
compared to 898 (50%) of those who did not link (P<.01).
Linked subjects were predominantly white (96%; n=417); there
were more blacks who did not link (6%; n=115; P<.01). Of
those who linked, 49% (215) were using biological agents
compared to 43% (767) of those who did not enroll (P=.02).
There were no significant differences in patterns of use for other
medication classes. Although there were no significant
differences in disease location in CD, linked subjects had a
mean HBI of 3.6 and those who did not link had a mean HBI
of 4.4 (P<.01). Among those subjects with UC, 40% (176) of
linked subjects had left-sided colitis compared to 27% (491) of
those who did not link and 45% (196) of linked subjects had
extensive colitis, compared to 60% (1066) of those who did not
link (P<.01). However, there was no difference in the mean
SCCAI score.
Figure 2. Recruitment efforts for the CCFA Partners/SHARE record linkage.
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Discussion
Principal Findings
This work represents a novel effort to link traditional cohorts
of subjects with IBDs to an electronic cohort of IBD subjects.
OSCCAR is the only US-based inception cohort of adult patients
with IBD. SHARE is a large multicentered cohort of IBD
subjects created to facilitate translational research. The
accompanying biobank of specimens is an invaluable aspect of
these cohorts. CCFA Partners is the largest US cohort of IBD
subjects with a primary focus on patient-reported health data.
The opportunity to leverage and enhance both cohorts through
corecruitment and linkage of data assets is quite intuitive. The
OSCCAR and SHARE cohorts are enriched through inclusion
of an expanded array of patient-reported data. Similarly, CCFA
Partners can provide a low-cost opportunity for the long-term
follow-up of OSCCAR and SHARE participants in the event
that funding for these cohorts ended. Conversely, for the portion
of CCFA Partners participants who are coenrolled in OSCCAR
or SHARE, the clinical data and biospecimens represent a
valuable resource. Similar linkages between CCFA Partners
and other clinical/translational cohorts will further expand the
amount and types of data available to researchers.
As the findings reveal, it was a challenge to achieve linkage
between the cohorts. Study staff worked diligently to use every
contact as an opportunity to encourage subjects to participate
in CCFA Partners. Although nearly 76% of the subjects who
were eligible initially consented to enroll in CCFA Partners and
link data, ultimately only 14% of those subjects who were
eligible completed the linkage. The SHARE cohort had slightly
more success with 24% of subjects linking to the CCFA Partners
cohort. There are still a number of valuable lessons to be learned
from this effort that both further inform the CCFA Partners
study and may help inform future research endeavors involving
record linkages.
CCFA Partners is an Internet-based cohort with most referrals
coming from the CCFA rather than a population-based or
randomly sampled cohort. The degree to which CCFA Partners
is more broadly representative of the larger IBD population is
largely unknown. However, systematic recruitment through the
OSCCAR community-based cohort and SHARE multicentered
cohort provided us the first opportunity to assess the
generalizability of CCFA Partners. Education, race, gender, and
disease activity for CD and location for UC appear to be factors
impacting the decision to participate in CCFA Partners. This is
important in understanding the generalizability of past and future
findings learned through CCFA Partners. We also note that
OSCCAR or SHARE participants who did not have access to
the Internet were excluded from this linkage study. Therefore,
additional demographic or clinical differences between the
CCFA Partners cohort and the general IBD population may
exist and will need to be evaluated in subsequent studies.
Data exploring factors contributing to participation in cohort
studies of chronic diseases are scarce. Our findings indicate that
education level was a very important driver of cohort linkage.
In the OSCCAR study, 17% of participants who successfully
linked possessed a doctoral degree compared with 3% of
participants who did not complete the linkage. Furthermore, a
higher percentage of participants who did not link had less than
a bachelor’s degree. One possible explanation for this difference
is that those with a doctoral degree valued the importance of
research endeavors and made it a priority to complete the
linkage. Education level was not available for the SHARE
cohort.
The SHARE experience revealed that gender and race may play
a role in completing linkage to an Internet-based cohort, with
a significantly higher percentage of women and white people
completing the linkage. It is possible that those who linked have
less aggressive disease than those who did not link. Among CD
patients, although there were no differences in disease
phenotypes, those who linked had a lower mean HBI. Among
UC patients, those who linked had less-extensive disease, even
though the mean SCCAI was the same between both groups.
To date, there is only one study examining factors in
participation in cohort studies of IBDs. A Swiss IBD cohort
reported that factors associated with nonresponse to an initial
survey were younger age, male gender, and depression in CD
only and longer disease duration in UC only. [31] These
differences were not noted in our experience. HIV/AIDS is the
disease process in which study participation has been most
studied. Unemployment, female gender, higher education, and
higher baseline CD4 counts predicted likelihood of participation
in HIV cohort studies [22-34]. A study of childhood cancer
survivors concluded that there were no substantive differences
explaining nonparticipation in a lifetime cohort study [35],
similar to our findings. Other groups described factors that
contribute to participation in studies in general. A cohort study
of employees at a large French utility company demonstrated
that male sex, being married, having children, being a manager,
and geography were predictors of participation [36]. However,
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this study likely cannot be generalized to cohort studies of
disease processes.
We speculate that recruiting participants into CCFA Partners
at the time of their enrollment in OSCCAR (the time of their
initial diagnosis) would have likely yielded more success in
linkage. The OSCCAR cohort started enrollment 3 years before
the initiation of the Partners cohort. It is possible that research
fatigue was a factor explaining the poor linkage. It is also
possible that the farther participants get from their diagnosis,
the more their initial enthusiasm to participate in research wanes.
SHARE participants were recruited at the time of the initial
SHARE consent. Although similar proportions of subjects
consented to enrollment, the SHARE experience demonstrated
slightly more success with completing the linkage. Future
investigators establishing new cohorts may want to anticipate
potential linkages and incorporate them into the initial
procedures at the beginning of the cohort. Indeed this is already
being implemented with CCFA Partners recruitment and linkage
incorporated into the design of the recently funded IBD Plexus
Prospective Clinical Cohort.
The main strength of this study was the leveraging of the
existing infrastructure of 3 well-developed cohorts. The primary
limitation, aside from the disappointing recruitment and linkage
results, is that we were not able to further explore reasons for
noncompletion of CCFA Partners enrollment and linkage.
Although interviews and surveys of OSCCAR and SHARE
participants to inquire about reasons for nonparticipation may
have been informative, we decided not to pursue this due to a
concern that this might jeopardize continued participation in
the cohorts themselves.
Conclusions
The linking of complementary cohorts may be a cost-effective
strategy for expanding research infrastructure and enabling
studies that might not be possible with either cohort alone. The
regulatory, legal, and technical challenges in creating and
implementing such linkages are not insurmountable; however,
in this pilot study, we observed that recruitment itself was the
substantial obstacle. Therefore, recruitment efforts for cohort
linkages need to be balanced against the potential returns. Based
on our experience, we would recommend a simultaneous, rather
than sequential, strategy for corecruitment for subsequent
attempts at cohort linkage. We believe that the lessons learned
from this novel effort serve well to inform future linkages both
in IBD and other chronic diseases.
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